Company

Janux Therapeutics

Biotechnology Research 10955 Vista Sorrento Pkwy 101 employees

Employees: 101
Contacts: 2
Emails: 2
Phones: 1

www.januxrx.com LinkedIn Crunchbase

Janux Therapeutics Overview

Headquarters: 10955 Vista Sorrento Pkwy
Website: www.januxrx.com
Industry: Biotechnology Research
Employees: 101
Founded: 2017
Funding: 350.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology

About Janux Therapeutics

Janux is a clinical-stage company developing unique immunotherapies that have the potential to generate tumor-specific immune responses to attack and kill tumors without destroying a patient’s healthy tissue. Janux is using its platform masking technology to engineer novel drug candidates that are designed to overcome the traditional T cell engager toxicity and efficacy limitations. Janux is proud to have earned a 𝐆𝐫𝐞𝐚𝐭 𝐏𝐥𝐚𝐜𝐞 𝐓𝐨 𝐖𝐨𝐫𝐤 𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧™ in 2024.

Janux Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Janux Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Eric Dobmeier			View
Andy Meyer		San Francisco, California, United States	Email Phone
Sheila Gujrathi, Md	Biotech Executive - Physician Scientist	San Diego, California, United States	View
Ilene Tat-Tong Cltd, Cscp, C.p.m., Cpsm®	Director, Supply Chain Professional	San Diego, California, United States	Email